Survey of Neonatal Management After Amnioinfusion for Anhydramnios
- PMID: 38315476
- PMCID: PMC10845040
- DOI: 10.1001/jamapediatrics.2023.6403
Survey of Neonatal Management After Amnioinfusion for Anhydramnios
Plain language summary
This survey study reports on use of renal replacement therapy, hemodynamic support, sedation, neuroimaging, and extracorporeal membrane oxygenation at Renal Anhydramnios Fetal Therapy trial sites for neonates with either bilateral renal agenesis or fetal kidney failure.
Conflict of interest statement
References
-
- Miller JL, Baschat AA, Rosner M, et al. . Neonatal survival after serial amnioinfusions for fetal bilateral renal agenesis: report from the RAFT trial. Am J Obstet Gynecol. 2023;228(1 suppl):S766-S767. doi:10.1016/j.ajog.2022.11.1307 - DOI
-
- Cameron D, Lupton BA, Farquharson D, Hiruki T. Amnioinfusions in renal agenesis. Obstet Gynecol. 1994;83(5 Pt 2):872-876. - PubMed
-
- Renal Anhydramnios Fetal Therapy (RAFT) . ClinicalTrials.gov identifier: NCT03101891. Updated June 13, 2023. Accessed December 15, 2023. https://www.clinicaltrials.gov/ct2/show/NCT03101891
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
